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Abstract 
 
Background: One-session treatment (OST) is a short-term massed exposure therapy for the treatment of specific phobias in 
children and adults. Systematic reviews have demonstrated the effectiveness of the treatment for children and adolescents 
across countries and age groups.  
Objective: A single-group open trial design was used to examine the feasibility and preliminary efficacy of OST for youths 
with specific phobias in a Danish context.  
Method: At the Anxiety Clinic of Aarhus University, 10 youths between the ages of 7 and 17 years who fulfilled the diagnostic 
criteria for specific phobias were treated in accordance with the OST manual. The participants were assessed via semi-
structured diagnostic interviews, clinician severity ratings, a behavioral approach test, and self- and parent report measures. 
Feasibility was assessed with the use of patient- and parent-report measures. Assessments were completed at before and after 
treatment and at the 3-month follow-up appointment.  
Results: All outcome measures changed significantly from the pretreatment period to the 3-month follow-up assessment. 
Four (40%) of the participants were free of the targeted specific phobia after treatment, and eight (80%) were free of the 
phobia at the 3-month follow-up. The families were moderately satisfied with the treatment, and no patients dropped out of 
the study.  
Conclusion: On the basis of the results of this pilot study, it may be tentatively concluded that OST could be useful for the 
treatment of youths with specific phobias in Denmark. 
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outcome 
 
 
 
 
Introduction 
Specific phobias are one of the most frequent mental 
disorders among children and adolescents (hereafter 
referred to as youths), with a lifetime prevalence of 
12.5% and a mean age of onset of 7 to 9 years (1). As 
a result of the high prevalence of this condition and 
the fact that specific phobias may interfere with daily 
functioning, there is a need to develop and enhance 
efficacious treatments. Furthermore, phobias during 
childhood may be a significant predictor of anxiety 
disorders later in life (2), so it may be important to 
start treatment as soon as possible.  
The Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV), categorizes 
specific phobias into five subtypes: animal type, 
natural environment type, blood-injection-injury 
type, situational type, and other type (e.g., loud 
noises) (3). The most frequently occurring phobia 
types in children and adolescents are the animal type 
and the natural environment type (4). 
The most frequent comorbid anxiety disorders in 
youth with specific phobias are post-traumatic stress 
disorder, obsessive-compulsive disorder, and anxiety 
not otherwise specified; however, other comorbid 
disorders are common as well (5). Fifty percent of 
youth with specific phobias suffer from at least one 
other specific phobia, and 25% suffer from another 
mental disorder (6). 
One-session treatment (OST) is a 3-hour massed 
single-session graduated exposure variant of 
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cognitive behavioral therapy (CBT) for the treatment 
of specific phobias (7). The treatment is based on 
evidence-based methods such as in vivo exposure, 
cognitive restructuring, psychoeducation, participant 
modeling, and reinforced practice. OST has been 
used to treat adults with specific phobias, and it has 
demonstrated positive long-term results over a 7.5-
year period, with 65% of treated patients diagnosis-
free and an additional 25% improved (7). Within the 
last decade, systematic reviews have also 
demonstrated the effectiveness of OST for the 
treatment of youth across different phobias, formats, 
countries, and age groups (8-10). Zlomke and Davis 
(8) found small to large uncontrolled effect sizes for 
OST from before to after treatment for the primary 
outcome measures of self-reports and observations 
of anxiety level. A systematic review by Davis and 
colleagues (10) concluded that OST demonstrated a 
significantly better treatment effect as compared with 
alternative treatments (e.g., eye movement 
desensitization and reprocessing, psychological 
placebo). On the basis of a narrative review of eight 
studies supporting the well-established status of OST 
for children with specific phobias, Ollendick and 
Davis (9) concluded that OST is the treatment of 
choice for children with specific phobias. Nielsen 
(11) investigated the effect of OST and found 
moderate to large (d = 0.6 to 3.26) uncontrolled 
effect sizes for the primary outcome measures from 
before to after treatment. Furthermore, when OST 
was compared with other active treatments, the 
controlled effect sizes of the outcome measures were 
small to moderate (d = 0.30 to 0.56), whereas small 
to large effect sizes (d = 0.15 to 3.39) were found 
when comparing OST with waitlisting. Fifty-four 
percent of the clients treated with OST were 
diagnosis-free after treatment.  
OST has been found to have an effect on 
comorbid disorders even though they are not the 
target of the treatment. Ost and colleagues (12) 
randomized 60 youths to three conditions: OST 
alone, OST with a parent present, or waitlisting. They 
found that the two OST conditions produced 
significant reductions in the clinical severity rating 
(CSR) of the comorbid disorders. Ollendick and 
colleagues (13) used data from an existing 
randomized controlled trial of OST to examine 
whether the treatment outcome was affected by a 
patient’s comorbid disorders and whether the 
treatment of the specific phobia had an effect on the 
co-occurring disorders. Results indicated that the 
presence of comorbid phobias and other anxiety 
disorders did not influence the treatment effect and 
that OST reduced the clinical severity of the 
comorbid specific phobias and other anxiety 
disorders not targeted by the treatment. 
Homework in the form of rehearsing the skills 
acquired during therapy in the youth’s natural 
environment is considered an important ingredient 
for maintaining or increasing treatment gains (14). A 
meta-analysis (15) found that the treatment of adults 
that included homework assignments yielded 
significantly better post-treatment outcomes as 
compared with treatment without homework, with a 
small controlled effect size (d = 0.48). However, the 
few studies of these effects in youths have yielded 
mixed results. Hughes and Kendall (16) found no 
significant associations between homework 
compliance and treatment outcomes when treating 
youths with mixed anxiety disorders. Arendt and 
colleagues (17) investigated different associations 
between homework and treatment outcomes and 
found no convincing evidence that homework 
compliance was related to the treatment outcomes of 
a CBT program for youths with mixed anxiety 
disorders. Alternatively, Park and colleagues (18) 
found a significant association between homework 
compliance and outcome in a CBT program for 
youths with a primary diagnosis of obsessive-
compulsive disorder. 
To produce better treatment outcomes, some 
studies have investigated the effect of adding a 
booster session to CBT. A recent meta-analysis of 53 
studies that included a total of 1937 youths showed 
that CBT interventions that included booster 
sessions were more effective than CBT treatments 
without booster sessions for youths with anxiety 
disorders (19). Pretreatment and post-treatment 
studies with booster sessions showed significantly 
larger effect sizes (r = .58) than studies without 
booster sessions (r = .45). The researchers 
hypothesized that the expectation of a booster 
session may exert an anticipatory effect on youth 
outcomes before the start of the actual booster 
sessions. Similarly, pretreatment to follow-up studies 
that involved booster sessions showed a significantly 
larger effect size (r = .64) than studies without 
booster sessions (r = .48) after controlling for 
demographic factors, primary diagnosis, and 
intervention characteristics (e.g. treatment modality, 
number of sessions). The effect of adding a booster 
session to the OST manual has not been investigated 
yet.  
 
Method 
Participants 
The participants were 10 youths (nine girls, one boy) 
with specific phobias who were between seven and 
17 years old (mean [M], 10.5 years; standard deviation 
[SD], 3.0 years). They were recruited from the waiting 
list and via the website of the Anxiety Clinic for 
Children and Adolescents at Aarhus University, 
Denmark, and via the website of Angstforeningen 
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(The Danish Anxiety Society). The first 10 children 
and adolescents who applied for treatment and who 
met the DSM-IV criteria for specific phobia were 
included in the study. The inclusion criteria were 
being between seven and 17 years old and having a 
specific phobia diagnosis in accordance with DSM-
IV. The exclusion criteria were as follows: 1) having 
a current diagnosis of severe behavioral disorder, 
untreated attention-deficit/hyperactivity disorder, 
selective mutism, autism spectrum disorder, 
intellectual disability, psychotic disorder, eating 
disorder requiring treatment, substance abuse, or 
depression; and 2) receiving other current treatment 
(psychotherapy or medical). The study was approved 
by the Ethical Committee of the local county and by 
the Danish Data Protection Agency. All parents 
signed written consent forms after the family had 
been given oral and written information about the 
treatment and before the youths began the treatment. 
The treatment was offered for free and took place at 
the Anxiety Clinic for Children and Adolescents at 
the Department of Psychology and Behavioural 
Sciences, Aarhus University, Denmark. 
 
Assessment 
Assessment before treatment 
Each youth’s motivation for the treatment was 
assessed on the basis of a shortened version of the 
Nijmegen Motivation List (20), which was developed 
by Ollendick and colleagues (21). This version has 15 
items that include statements such as “I believe that 
this is the right treatment for me” and “I’m certain 
that I will also practice at home the things I learn in 
treatment.” The statements are rated from 0 (not at 
all true) to 2 (mostly true). The results range from 0 
to 30, and scores of less than 15 are considered to 
represent youths with poor motivation. Ollendick 
and colleagues (21) found an internal consistency of 
0.73. In the present study, the Cronbach’s alpha 
coefficient was 0.65. 
The parent’s credibility and expectations in relation 
to the treatment were assessed with the 
Credibility/Expectancy Questionnaire (22), which 
consists of four questions regarding what the parent 
thinks about the treatment and two questions 
regarding what the parent feels about the treatment. 
The credibility subscale was derived from the first 
three “think” questions (e.g., “At this point, how 
successful do you think this treatment will be in 
reducing your child’s anxiety symptoms?”), and the 
expectancy subscale was derived from the fourth 
“think” question and the two “feel” questions (e.g., 
“How much do you think that your child’s anxiety 
symptoms will have improved by the end of the 
therapy period?”). Four of the items were rated on 
scales that ranged from 1 (not at all logical/ 
useful/confident) to 9 (very logical/useful/ 
confident), and the other two were rated on an 11-
point scale from 0% to 100%. During the scoring of 
the questionnaire, the 11-point scale items were 
recoded to make them comparable with the 9-point 
scale items. During the recoding process, values from 
40% to 60% on the 11-point scale were merged into 
one value that corresponded with 5 on the 9-point 
scale. This way of scoring the questionnaire is 
consistent with how the questionnaire has been 
scored in other studies (23). A total score between 3 
and 27 for each subscale was calculated for the 
mothers and fathers, with higher scores indicating 
high credibility and positive expectations regarding 
the treatment. The whole scale has a Cronbach’s 
alpha coefficient between 0.84 and 0.85. The 1-week 
test-retest reliability was found to be good for both 
the expectancy (r = 0.82) and the credibility (r = 0.75) 
questionnaire (22). In this study, the Cronbach’s 
alpha coefficient of the whole scale was 0.93 for 
mothers and 0.91 for fathers. 
 
Outcome measures 
The Anxiety Disorders Interview Schedule for DSM-
IV, Child and Parent Versions (ADIS-IV-C/P) (24) 
is a semi-structured diagnostic interview for the 
assessment of anxiety, including specific phobia, in 
children and adolescents. Interviews are conducted 
separately for the youths and their parents. For the 
ADIS-IV-C/P, all diagnoses are given a CSR from 0 
(no symptoms) to 8 (very severe), with a rating of 4 
or higher suggesting a clinical level of interference by 
the specific phobia or other assessed disorders. 
Separate CSRs are made by youth, parents, and 
clinicians; in this study, only the clinicians’ CSRs are 
reported.  
The ADIS-IV-C/P interviews were conducted by 
the first and second authors of this study, who were 
master’s students at the clinic. They were both 
trained in the use of the ADIS-IV-C/P. The training 
consisted of watching two gold standard interviews 
on video, observing two live interviews, and 
conducting one satisfactory ADIS-IV-C/P interview 
with a client while an experienced ADIS-IV-C/P 
assessor observed. Both authors had also conducted 
several ADIS-IV-C/P interviews before working on 
this study. They conducted the pretreatment, post-
treatment, and follow-up ADIS-IV-C/P interviews 
for the youths that they did not treat with therapy 
(each student was the therapist for 5 children). They 
received supervision during all of their interviews at 
all time points from a clinician at the clinic who did 
not take part in the treatment. 
The ADIS-IV-C/P has shown acceptable 7- to 14-
day test-retest reliability for the children and parents 
combined (K = 0.62 to 1.00) (25). Inter-rater 
reliability has been found to be acceptable for parent 
interviews (K = 0.77) (26). The diagnosis of specific 
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phobia with the ADIS-IV-C/P is convergent with 
high scores on the Fear Survey Schedule for 
Children, Revised (27). To assess the reliability of the 
specific phobia diagnosis for which a youth was 
receiving treatment, independent assessors reviewed 
the videotaped interviews. There was agreement 
about diagnosis for nine (90%) of the 10 children, 
and the interclass correlation coefficient for the CSR 
of the specific phobia diagnosis was 0.65. 
The Behavioral Approach Test (BAT) is a 
therapist-engineered controlled situation in which 
the participant has to approach the feared stimulus. 
The BAT can be used as an objectively observed 
measure of the avoidance of the feared stimulus (28); 
it was used for this purpose in earlier studies of the 
effectiveness of the OST (12,21). Ollendick and 
colleagues (21) found a test-retest reliability of 0.87 
for the percentage of steps undertaken in the BAT. 
A specific BAT was made for each of the four 
specific phobias included in the study: dogs, 
darkness, heights, and being alone. Each BAT 
consisted of 11 or 12 steps during which the 
participants were gradually exposed to the feared 
stimulus. To provide a reliable measure of the degree 
of avoidance, the participants were instructed to go 
as far as they could. However, they were also told that 
they could stop at any time if they became too 
anxious. The participants were further instructed to 
stay at the stopping point, where they were asked to 
rate their subjective units of distress. The therapist 
did not interfere during the BAT. 
Because the number of steps varied from one BAT 
to another, the percentage of completed steps was 
used for analysis. This kind of analysis has been used 
in other studies (12,21). All of the BATs were 
performed in vivo, using live dogs or live situations 
(i.e., a dark room, balconies at different levels, and 
being alone). 
The Fear Thermometer is a scale that ranges from 
0 (not at all) to 8 (very much) and that can be used to 
rate the individual’s degree of fear at different time 
points (29). The Fear Thermometer was used to 
measure the participant’s subjective units of distress 
during the BAT: before entering the BAT, at the 
stopping point, and 10 minutes after the BAT. 
Ollendick and colleagues (21) found a test-retest 
reliability of 0.92 for the Fear Thermometer. 
The Fear Survey Schedule for Children, Revised 
(FSSC-R), is a self-report measure in which youths 
rate their fear of 80 different objects or situations on 
a 3-point scale (“none”, “some” or “a lot”). High 
scores on the FSSC-R indicate the presence of 
significant fear and the possible presence of specific 
phobia. Weems and colleagues (30) found that the 
FSSC-R is useful for differentiating among types of 
phobias. The internal reliability (α = 0.96) and the 1-
week test-retest reliability (r = 0.90) for this measure 
are high (31). In addition, the FSSC-R has been 
found to be stable over time (32). In this study, the 
Cronbach’s alpha coefficient of the FSSC-R was 
0.97. 
The Self-Efficacy Questionnaire for Children 
(SEQ-C) contains 24 items that represent three 
domains of self-efficacy: 1) social self-efficacy 
(perceived capability to be included in peer 
relationships); 2) academic self-efficacy (perceived 
capability to master academic subjects); and 3) 
emotional self-efficacy (perceived capability to cope 
with negative emotions). Each item is scored on a 5-
point scale from 1 (not at all) to 5 (very well) (33). 
The internal consistency reliability of the total self-
efficacy score is satisfactory (α = .88) (33). In this 
study, the Cronbach’s alpha coefficient was 0.78.  
At the 3-month follow-up, the youth and the 
parents were asked how much time the youth had 
spent practicing confronting the specific phobia on a 
daily basis since the completion of treatment. The 
answer categories were 0, 5, 10, 20, 30, 40, 50, and 60 
minutes and more than 60 minutes. The last category 
(more than 60 minutes) was not used by any raters. 
This questionnaire will hereafter be referred to as the 
Estimated Amount of Training (EAT). 
The youths and their parents were asked to 
complete the Experience of Service Questionnaire 
developed by the Anxiety Clinic at Aarhus University 
and inspired by the work of Attride-Stirling (34). This 
questionnaire assesses both youth and parent 
satisfaction with the treatment after treatment 
completion. Both the youths and their parents were 
asked to rate nine statements regarding their 
experience with the treatment as 0 (not true), 1 (partly 
true), or 2 (true). They were also asked to rate 
whether, in their opinions, the anxiety and avoidance 
of the youth changed from before to after treatment 
on a scale from 1 (a lot worse/more) to 7 (a lot 
better/less). The parents were asked to quantify any 
improvement they saw in the anxiety symptoms of 
their children. In addition, the parents were asked if 
there was something that they liked or disliked about 
the treatment and if there was anything that could be 
improved. 
 
Procedure 
Table 1 provides an overview of the measures used 
in the treatment process and the time points at 
which they were administered. 
 
Procedure before treatment 
After a youth had been referred to the study, a 
therapist performed a preliminary screening by 
phone with the youth’s parents. If the parents’ 
description of the symptoms passed the screening, an 
appointment for the diagnostic interview was made, 
and information about the study was mailed to the 
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family. At the first meeting, the child and the parents 
were separately interviewed using the ADIS-IV-C/P, 
and the family signed the informed consent form. 
Electronically administered rating scales (i.e., 
Nijmegen Motivation List, Credibility/Expectancy 
Questionnaire, FSSC-R, and SEQ-C) were e-mailed 
to the families to be completed before their first 
appearance at the clinic and at all assessment points.  
 
 
 
 
TABLE 1. Summary of the Study Measures 
 
 Measure Intake Before 
Treatment 
After 
Treatment 
3-Month 
Follow-up 
Parent ADIS-IV-C/P about child X  X X 
Youth ADIS-IV-C/P about self X  X X 
Clinician ADIS-IV-C/P (CSR) X  X X 
Youth NML X    
Parent CEQ X    
Youth BAT  X X X 
Youth FT  X X X 
Youth FSSC-R X  X X 
Youth EAT    X 
Parent EAT    X 
Youth ESQ   X  
Parent ESQ   X  
Parent Demographic questionnaire X    
Youth SEQ-C X  X X 
ADIS-IV-C/P, Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, Child and Parent versions; BAT, Behavioral Approach Test; CEQ, Credibility/Expectancy 
Questionnaire; CSR, Clinical Severity Rating; EAT, Estimated Amount of Training; ESQ, Experience of Service 
Questionnaire; FSSC-R, Fear Survey Schedule for Children, Revised; FT, Fear Thermometer; NML, Nijmegen 
Motivation List; SEQ-C, Self-Efficacy Questionnaire for Children 
 
 
 
 
Procedure after treatment and at follow-up 
One week after treatment and at the 3-month follow-
up, the child and the parents were interviewed using 
a reduced version of the ADIS-IV-C/P that included 
only sections for which the youth fulfilled the 
diagnostic criteria at the pretreatment screening. The 
families filled in the self-report forms after treatment 
and at the 3-month follow-up. After treatment, the 
family was asked about their experience with the 
treatment using the Experience of Service 
Questionnaire. At the 3-month follow-up, the family 
was also asked to complete the EAT. The 
participants who did not respond to the treatment 
were offered additional group or individual treatment 
in the clinic. 
 
Therapists  
The first and second authors of this study were 
therapists and master’s students at the clinic. They 
had attended a seminar on OST given by Lars-Goran 
Ost, but they had no prior experience treating youths 
with specific phobias using the OST manual. 
However, as part of the master’s program in 
psychology, the therapists had been providing 
supervised treatment to youths with specific phobias 
and other anxiety disorders for a year using the Cool 
Kids Program at the Anxiety Clinic, Aarhus 
University. 
 
Treatment 
The youths were treated for specific phobias of 
darkness (n = 4), dogs (n = 4), heights (n = 1), and 
being alone (n = 1). The treatment consisted of four 
parts: a pretreatment meeting, a treatment session, a 
post-treatment meeting, and a booster session. The 
first three parts followed the manual for OST (35), 
and the booster session was added for this study. 
 
Pretreatment 
One week before the treatment session, the therapist 
and the youth met for a clinical interview that lasted 
45 to 60 minutes. The pretreatment plan was based 
on the Functional Assessment Worksheet developed 
by Davis and colleagues (36). The youth was 
encouraged to describe his or her catastrophic 
cognitions, maintaining factors, previous exposures, 
and stimulus characteristics. A fear hierarchy was 
developed in collaboration between the youth and 
the therapist, and the rationale and the content of the 
treatment were explained to the youth. It was made 
clear that the treatment was a joint effort between the 
therapist and the youth. The therapist assured the 
youth that he or she would not be exposed to a 
stimulus without prior warning. At the end of the 
session, the BAT was carried out. 
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Treatment session 
The outcome goal of the treatment session was that 
the youth would be able to handle situations that he 
or she could not cope with before the treatment 
because of the specific phobia. The OST was used to 
show the youth that the dreaded consequences that 
he or she expected to happen when exposed to the 
feared stimulus or situation actually did not occur. 
This was done through controlled exposure of the 
youth to the feared stimulus or situation. The main 
element of the treatment was the massive in vivo 
exposure, during which the youth’s catastrophic 
cognitions were confronted in gradually more 
challenging behavioral experiments. The youth had 
to stay in the situation until his or her anxiety 
decreased at least 50% according to the Fear 
Thermometer and preferably until it had vanished 
completely. It was important that the youth not be 
pushed into unexpected exposures. Rather, the youth 
and therapist continuously worked together on the 
next step. If it was helpful for the youth, the therapist 
could perform a step before the youth did as part of 
the exposure. The treatment session was limited to 
three hours. 
 
Post-treatment  
One week after the treatment session, the youth and 
therapist met again. The youth was asked to repeat 
the rationale of the treatment and to remember how 
the rationale was connected to the phobia. The 
treatment session was summed up by looking back at 
what the youth’s problem looked like before 
treatment and how the catastrophic thoughts had 
gradually changed during the session. Furthermore, 
the youth was told that it is important to continue 
working with the skills achieved during the treatment 
for the next 6 months to maintain treatment gains. 
At the end of the meeting, instructions for how to 
deal with potential setbacks were given. The post-
treatment session lasted 30 to 45 minutes. 
 
Booster session 
Three months after the treatment session, the 
therapist, the youth, and the parents met for the last 
time. The therapist asked the family how successful 
the training had been since the post-treatment 
session and if they had experienced any difficulties 
with continuing the training. If the family had 
forgotten or did not understand specific elements of 
the treatment, these elements were explained again. 
The booster session is not a part of Ost’s original 
program (7), but it was included in the present study 
because it was hypothesized that a booster session 
would improve homework compliance and thereby 
increase treatment gains. 
 
 
Statistical analysis 
Within-group changes in the primary outcome 
measures and the SEQ-C scores from the three 
points in time were examined to evaluate treatment 
effects. Not all of the data were normally distributed. 
However, because the parametric paired samples t-
test yielded results similar to the non-parametric 
alternative Wilcoxon signed-rank test, the results of 
the parametric test are reported. Effect sizes were 
calculated with the use of Cohen’s d (37). Remission 
rates were examined using percentages. 
Stepwise multiple regression analyses were 
conducted with the total ADIS-IV-C/P CSR scores 
at the 3-month follow-up as the criterion variables. 
The post-treatment total ADIS-IV-C/P CSR 
criterion variable was inserted as the first step, and 
EAT was inserted as the second step. Separate 
analyses were conducted on the basis of the EAT 
reports of each youth and his or her mother and 
father. Analyses were based on all 10 participants. 
Because the mother of one of the youths (Patient ID 
no. 6) reported an EAT far higher than either the 
father or the youth, the mother’s score was 
interpreted as an error and replaced by the same 
score that the youth had reported. All statistical 
analyses were carried out using Statistical Product 
and Service Solutions software version 20. 
 
Results 
All participants completed the treatment, including 
the post-treatment and follow-up sessions. Thus, 
there were no dropouts from treatment. 
At the pretreatment assessment, the youths had an 
average of 3.6 anxiety diagnoses (SD, 3.4). Six of the 
10 participants had at least one additional disorder 
besides the specific phobia. Two of the youths had 
other specific phobias, and the other four had three 
or more comorbid anxiety disorders. The diagnoses 
included other specific phobias [14], generalized 
anxiety disorder [4], social phobia [3], and separation 
anxiety disorder [2]. An overview of the specific 
disorders of each participant is presented in Table 2. 
The youths’ motivation score on the shortened 
version of the Nijmegen Motivation List had a mean of 
22.5 (SD, 3.1; range, 16 to 27) out of the possible 
maximum of 30 points. Because none of the 
participants’ scores were less than 15, all participants 
were considered to be motivated to complete the 
treatment (21). 
The credibility of the treatment was relatively high 
for the mothers (M, 20.2; SD, 3.6) and the fathers (M, 
19.6; SD, 4.0), with a maximum score of 27. The 
expectancy score was moderate for the mothers (M, 
16.0; SD, 5.0) and the fathers (M, 17.0; SD, 4.2), also 
with a maximum score of 27. One question—“How 
much do you expect that your child’s anxiety 
symptoms will have improved by the end of the 
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treatment?”—was analyzed separately to compare 
the expected improvement before treatment with a 
similar question asked after treatment, when the 
parents were asked about how large of an 
improvement they noticed in their children’s anxiety 
symptoms after the end of treatment. Nineteen out 
of 20 parents answered the question, which was rated 
on an 11-point scale from 0 to 100%. All parents 
expected at least some change in their children’s 
anxiety symptoms. Thirteen (68.4%) expected that 
their children’s anxiety symptoms would improve by 
50% or more.
 
 
 
TABLE 2. Diagnoses and Clinical Severity Ratings before treatment, after treatment, and at 3-Month Follow-up 
 
Patient 
ID No. 
Diagnoses Before Treatment (CSR) Diagnoses After Treatment (CSR) Diagnoses at 3-Month Follow-up 
(CSR) 
1 SP darkness (6) SP darkness (5) SP darkness (3) 
2 SP darkness (7) 
GAD (7) 
SAD (6) 
SoP (4) 
SP throwing up (8) 
SP elevators (5) 
SP flights (4)  
SP spiders (4) 
SP dentists (7) 
SP ferry (4) 
SP darkness (6) 
GAD (4) 
SAD (6) 
SoP (3) 
SP throwing up (8) 
SP elevators (4) 
SP flights (5) 
SP spiders (2) 
SP dentists (6) 
- 
- 
GAD (4) 
SAD (4) 
SoP (7)  
SP throwing up (7) 
SP elevators (2)  
- 
- 
- 
- 
3 SP dogs (6) 
GAD (7) 
SoP (4) 
SP darkness (4) 
SP needles (5) 
SP blood (5) 
SP elevators (5) 
SP dentists (4) 
SP roller coasters (4) 
SP dogs (7) 
GAD (6) 
SoP (6) 
SP darkness (6) 
SP needles (2) 
SP blood (5) 
SP elevators (5) 
SP dentists (6) 
SP roller coasters (1) 
SP animals (7) 
GAD (7) 
- 
- 
- 
- 
SP elevators (6) 
SP dentists (4) 
- 
4 SP heights (4) 
SoP (5) 
GAD (7) 
SP insects (5) 
- 
SoP (6) 
GAD (5) 
SP insects (6) 
- 
SoP (6) 
GAD (3) 
SP insects (6) 
5 SP darkness (5) 
SP loud noises (4) 
- 
SP loud noises (4) 
- 
- 
6  SP darkness (5) - - 
7 SP dogs (6) SP dogs (4) SP dogs (3) 
8  SP being alone (7) 
SAD (5) 
GAD (6) 
SP insects (7) 
SP darkness (6)  
SP being alone (6) 
SAD (5) 
GAD (4) 
SP insects (2) 
SP darkness (4)  
- 
- 
- 
SP insects (3) 
- 
9  SP dogs (7) 
SP cats (6) 
SP dogs (6) 
SP cats (6) 
SP dogs (6) 
SP cats (6) 
10 SP dogs (5) - - 
Note: CSR, Clinical Severity Rating; GAD, generalized anxiety disorder; SAD, separation anxiety disorder; SoP, social phobia; SP, 
specific phobia 
 
 
 
 
More than half (55%) of the parents felt that their 
children’s anxiety symptoms improved by 50% or 
more. Thus, the experienced improvement after 
treatment was less than the expected improvement 
before treatment. All parents noticed at least a small 
(10%) improvement in their children’s symptoms, 
but none of the parents felt that the symptoms had 
completely disappeared.   
The CSR scores decreased significantly from 
before to after treatment and from pretreatment to 
3-month follow-up, with large effect sizes. There was 
no significant difference between post-treatment and 
3-month follow-up scores, but the effect size was 
moderate. The total ADIS-IV-C/P CSR for all 
diagnoses decreased significantly from before to after 
treatment, from pretreatment to 3-month follow-up, 
and from post-treatment to 3-month follow-up, with 
small to large effect sizes (Table 3). 
After treatment, four participants (40%) were free 
of the specific phobias that were treated; at the 3-
month follow-up, eight participants (80%) were. 
Furthermore, at both the post-treatment and 3-
month follow-up evaluations reductions, in the 
severity of the comorbid disorders were found for 
five (83.3%) of the six participants with comorbid 
disorders diagnosed before treatment. After 
treatment, two participants (20%) were free of all 
diagnoses; at the 3-month follow-up, six participants 
(60%) were diagnosis-free. Table 2 shows an 
overview of the changes in the diagnoses over time 
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for the 10 participants. The specific phobias that 
were treated are highlighted.  
The percentage of steps completed during the BAT 
increased significantly from before to after treatment 
and from pretreatment to 3-month follow-up, with 
large effect sizes. The difference between the post-
treatment and 3-month follow-up evaluations was 
not significant, and the effect size was small (see 
Table 3).  
The rating of subjective fear at the stopping point 
of the BAT decreased significantly from before to 
after treatment and from pretreatment to 3-month 
follow-up, with large effect sizes. The difference 
between post-treatment and 3-month follow-up was 
not significant, and the effect size was small (see 
Table 3).
 
 
TABLE 3. Pretreatment, Post-treatment and 3-Month Follow-up Primary Outcome Measures 
 
Outcome 
Measure  
Pre-
treatment 
Mean (SD) 
Post-
treatment 
Mean (SD) 
3-Month 
Follow-up 
Mean (SD) 
t Value, Pre-
treatment to 
Post-
treatment 
(df) 
t Value, Pre-
treatment to 
3-Month 
Follow- up 
(df) 
t Value, 
Post-
treatment to 
3-Month 
Follow-up 
(df) 
Pre-
treatment to 
Post-
treatment 
Effect Size  
Pre-
treatment to 
3-Month 
Follow- up 
Effect Size  
Post-
treatment to 
3-Month 
Follow- up 
Effect Size 
ADIS-IV-C/P 
CSR for the 
specific 
phobia 
treated with 
OST 
5.8 (1.0) 3.4 (3.0) 1.9 (2.7) 3.5 (9)** 
 
4.9 (9)*** 1.9 (9) 1.1 1.9 0.5 
Total ADIS-
IV-C/P CSR 
for all 
diagnoses 
19.6 (18.3) 15.1 (16.7) 8.4 (9.7) 3.6 (9)** 3.1 (9)* 2.4 (9)* 0.3 0.8 0.5 
Percentage 
of BAT steps 
completed 
42.6 (31.3) 69.5 (36.5) 80.0 (32.8) 
 
-3.1 (9)* -3.8 (9)** -2.1 (9) 0.8 1.2 0.3 
Subjective 
fear as 
measured by 
the FT at the 
BAT stopping 
point 
6.6 (1.0) 2.6 (2.2) 2.3 (1.9) 4.7 (8)** 5.3 (8)*** 1.0 (8) 2.3 2.8 0.2 
FSSC-R score 144.9 (31.2) 129.8 (31.1) 120.4 (32.8) 3.6 (9)** 5.5 (9)**** 3.5 (9)** 0.5 0.8 0.3 
SEQ-C score 79.6 (11.3) 83.7 (17.0) 86.1 (17.8) -1.1 (9) -2.1 (9) -0.7 (9) 0.3 0.4 0.1 
*p < .05; **p < .01; ***p ≤ .001; ****p < .001 
ADIS-IV-C/P, Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Child and Parent versions; BAT, 
Behavioral Approach Test; CSR, Clinical Severity Rating; DF, differential; FSSC-R, Fear Survey Schedule for Children, Revised; FT, Fear Thermometer; OST, one-
session treatment; SD, standard deviation; SEQ-C, Self-Efficacy Questionnaire for Children 
 
 
 
 
 
Twenty-eight (93.3%) of the youths and their 
parents found that the treatment had helped the 
youths, at least partly; only one parent and one youth 
did not find the treatment helpful. Twenty-nine 
(96.7%) of the youths and their parents would 
recommend the treatment to others with similar 
problems. Only one parent would not recommend 
the treatment. Except for one youth, one mother, 
and one father from different families, all families 
answered “not true” to the following statement: 
“The treatment was causing me/my child to feel 
worse.” The parents were also given an open-ended 
question: “Was there something that you didn’t like 
or that can be improved?” Only eight (40%) of the 
parents answered the question. Half of the responses 
were concerns about the shortness of the treatment. 
One parent suggested that the treatment could be 
improved by adding another exposure session. 
Twelve (60%) of the parents answered the question, 
“What was good about the treatment?” Two answers 
in particular appeared most often: that they felt that 
they were in safe hands with the therapists (n = 5) 
and that they found the development and 
implementation of the fear hierarchy to be helpful (n 
= 4). 
The FSSC-R scores decreased significantly with all 
three comparisons: before to after treatment, with 
moderate effect sizes; pretreatment to 3-month 
follow-up, with large effect sizes; and post-treatment 
to 3-month follow-up, with small effect sizes (see 
Table 2). 
No significant differences in self-efficacy were 
found between the three time points. The effect size 
from post-treatment to 3-month follow-up was less 
than small, the effect size from before to after 
treatment was small, and the effect size from 
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pretreatment to 3-month follow-up was small to 
moderate (see Table 3). 
Table 4 shows the EAT that the youth had, on 
average, spent on a daily basis confronting the phobia 
treated during the OST according to the youth, the 
mother, and the father. Youths reported having 
spent an average of 20.5 minutes (SD, 23.4 minutes) 
per day practicing confronting their specific phobias. 
Mothers reported that their children spent an average 
of 17.0 minutes (SD, 14.9 minutes), and fathers 
reported an average of 13.0 minutes (SD, 15.1 
minutes). At 3-month follow-up, the total ADIS-IV-
C/P CSRs after treatment and the EATs reported by 
the youths, the mothers, and the fathers were 
significant with regard to their prediction of the total 
ADIS-IV-C/P CSRs: the more time that a youth 
spent practicing, the lower the total ADIS-IV-C/P 
CSR. Table 5 shows the results of the multiple 
regression analyses at 3-month follow-up. 
 
 
 
TABLE 4. Daily Number of Minutes Spent Confronting the Specific Phobia 
Between the Post-treatment and 3-Month Follow-up Evaluations 
 
Patient ID No. Youth’s Report Mother’s Report Father’s Report 
1 5 5 10 
2 40 30 10 
3 60 30 30 
4 5 5 5 
5 10 10 5 
6 10 10* 5 
7 5 15 5 
8 60 50 50 
9 5 10 5 
10 5 5 5 
*This number was adjusted; see the Statistical Analysis section of the text 
 
 
 
TABLE 5. Summary of Multiple Regression Analyses of Total Clinical Severity Ratings of Anxiety Disorder Interview 
Schedule for the DSM-IV, Child and Parent versions, at 3-Month Follow-up Evaluations 
 
  Criterion Variables 
 Total ADIS-IV-C/P CSR at 3-Month Follow-up (N = 10) 
Step Predictor Variables β ΔR2 p 
1 Post-treatment total ADIS-IV-C/P CSR 1.378 .836 .000 
2 Youth-reported homework -.593 .137 .001 
1 Post-treatment total ADIS-IV-C/P CSR 1.230 .836 .000 
2 Mother-reported homework -.469 .120 .003 
1 Post-treatment total ADIS-IV-C/P CSR 1.118 .836 .000 
2 Mother-reported homework  .386 .108 .008 
Note. ADIS-IV-C/P, Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition, Child and Parent versions; CSR, Clinical Severity Rating 
 
 
 
 
Discussion 
This pilot study evaluated the OST program for 
youths with specific phobias at the Anxiety Clinic for 
Children and Adolescents at Aarhus University in 
Denmark using a single group open trial design. This 
is the first time that the program has been evaluated 
in Denmark.  
There were no dropouts from the treatment, and 
both parents and youth expressed a moderate degree 
of satisfaction with the treatment. None of the 
youths or their parents reported that the treatment 
was causing the youth to feel worse, and nine of the 
youths (90%) and 19 of the parents (95%) found the 
treatment to be at least partly helpful. Most of the 
families would recommend the treatment to a friend 
in a similar situation. More than half of the parents 
(55%) expressed that they saw an improvement of 
50% or more in their children’s symptoms after the 
end of treatment. Thus, although the treatment 
seemed to be well accepted, the treatment 
satisfaction rate could have been higher. A possible 
reason for the moderate satisfaction score could be 
that the improvements of the youth observed by the 
parents did not correspond with the expectations of 
the parents before the treatment began. This may 
also explain why four parents stated that the 
treatment was too short. Had there been a 
satisfaction assessment at the 3-month follow-up 
evaluation, the scores may have been higher, because 
there were significant improvements in the FSSC-R 
scores and total ADIS-IV-C/P CSRs for all 
diagnoses between the post-treatment and 3-month 
follow-up meetings. In addition, the total number of 
youths who were diagnosis-free regarding the treated 
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phobia doubled from the post-treatment evaluation 
to the 3-month follow-up. 
Significant improvements were seen from before 
to after treatment and from post-treatment to 3-
month follow-up on all outcome measures except for 
self-efficacy. At the post-treatment assessment, four 
of the participants (40%) were free of the specific 
phobia that was treated, and this number had 
doubled by the time of the 3-month follow-up 
evaluation (80%). 
In this study, the percentage of participants who 
were free of the specific phobia after treatment was 
below the average of 54% that was found in a review 
of the current status of OST (11). One possible 
reason for this may be that the therapists in this study 
had no prior experience with the use of the OST 
manual. Only two other studies have examined the 
number of youths who were diagnosis-free of the 
specific phobia at follow-up after treatment with 
OST. Ollendick and colleagues (38) found that 
67.4% of youth were diagnosis free at 6-month 
follow-up; in a previous study, Ollendick and 
colleagues (21) had found that 49% of youth were 
diagnosis-free at that time point. As compared with 
the results of these two studies, the current study had 
better 3-month follow-up results. The addition of a 
booster session may have positively influenced the 
results of the present study.  
One possible mediator of the improvement seen 
from the time of the post-treatment evaluation to the 
3-month follow-up may be the amount of time spent 
confronting the specific phobia after the end of 
treatment. This hypothesis is supported by the 
results: the amount of homework completed 
between the post-treatment meeting and the 3-
month follow-up appointment significantly 
predicted the total ADIS-IV-C/P CSR at follow-up 
after controlling for the total ADIS-IV-C/P CSR 
after treatment. It is difficult to compare this finding 
with other studies that have investigated the effect of 
homework. Although the current study only has one 
retrospective measure of homework, other studies 
have investigated the effect of homework in longer 
treatment programs, where homework has often 
been rated on a weekly basis. It is possible that our 
measure was more biased than would be the case if 
the homework had been rated on a weekly basis. 
No other studies that have investigated the 
effectiveness of OST have examined the influence of 
homework on the outcome variables, so it is not 
possible to compare the results of this study with 
other studies of OST. 
The results of this study are in line with the results 
of the meta-analysis by Kazantzis and colleagues 
(15), which found that treatments of adults that 
included homework assignments yielded significantly 
better results than treatments without homework. 
Because the results of using homework assignments 
when treating youths with anxiety are mixed (16-18), 
more studies are needed to investigate this 
association further. 
Although the treatment described in the current 
study only focused on the targeted specific phobia, 
the severity of the comorbid disorders was reduced 
after treatment and at 3-month follow-up. These 
findings are in line with those of earlier studies 
(12,13), which have demonstrated that OST also 
reduces the severity of non-targeted comorbid 
disorders. Participants may be able to generalize the 
skills acquired from this time-limited treatment to 
other situations. Ost and colleagues (12) suggested 
that the increase in self-efficacy that is usually found 
after OST (39) helps participants to deal with their 
problems in more constructive ways, which leads to 
improvements in their symptoms. However, no 
increase in self-efficacy over time as measured by the 
SEQ-C was found in the present study. During the 
exposure portion of the treatment, many of the 
youths were observed verbalizing statements such as 
“I can already feel a difference. Yesterday I wouldn’t 
dare to have done what I just did” and “I did not 
believe that I was able to do it so fast.” When leaning 
her body over a fifth-floor railing, one of the youths 
with a specific phobia of heights exclaimed, “It’s 
crazy, I don’t think I ever have been so high up. I can 
easily live in an apartment on the sixth floor.” The 
responders seemed to be proud of their 
accomplishments, and these feelings may be 
generalizable and help them to deal with other 
comorbid conditions after successful treatment. This 
effect on untreated comorbid disorders is 
noteworthy, because standard treatment for 
generalized anxiety disorder, separation anxiety 
disorder, and other similar conditions typically 
requires 10 to 16 CBT sessions (13).  
Although the follow-up results were promising, 
two of the participants (20%) were still suffering 
from the treated specific phobia. The two non-
responders had very different characteristics before 
entering treatment. One of them had only one 
comorbid disorder, whereas the other had six 
additional specific phobias and two other comorbid 
conditions. Because low motivation is associated 
with low treatment response, this could have been a 
predictor of non-response. The two non-responders 
had scores of 20 and 26 for the shortened version of 
the Nijmegen Motivation List. The average 
motivation score was 22.5, with a standard deviation 
of 3.1. The score of 20 is within one standard 
deviation below the mean, and the score of 26 is just 
above one standard deviation from the mean. 
Therefore, their motivation does not seem to be a 
factor that can explain the non-response. The non-
responder group did not appear to have any 
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characteristics that differed from the responding 
group, except for the fact that the non-responders 
were among the youngest participants. It could be 
interesting for a future study with a bigger sample 
size to investigate whether age predicts non-response 
to OST. 
Because the two non-responders had no 
differentiating characteristics, the reason for non-
responsiveness may be associated with the treatment. 
This could be an issue if the functional assessment 
did not reveal the relevant cognitions associated with 
the specific phobia or if the most relevant phobic 
stimulus was not used in the treatment. It has been 
suggested that it may sometimes be necessary to 
administer a second or a third session of OST to 
produce a better treatment outcome (9). Future 
studies should investigate when the addition of 
another treatment session improves treatment 
outcomes, especially among non-responding youths.  
 
Limitations of the study 
The results of this study should be viewed with 
caution due to the most important limitations: the 
small sample size and the lack of randomization to a 
control group, which limited the internal validity of 
the study. Future studies should investigate the 
effectiveness of OST as compared with active and 
passive control groups in Denmark, and they should 
include larger sample sizes. Another limitation is the 
lack of a comparison group treated with the standard 
OST procedure without the addition of the booster 
session. 
In addition, the same two individuals served as 
assessors, therapists, and researchers. Although the 
results of the post-treatment and 3-month follow-up 
assessments were discussed with an external assessor, 
the results may be biased. The therapists did not have 
prior experience using the OST manual, and the 
therapists’ adherence to the manual was not assessed.  
 
Conclusion 
On the basis of the results of this small single group 
pilot study, it can be tentatively concluded that OST 
may be useful for the treatment of Danish youths 
with specific phobias. Significant improvements in all 
primary outcome measures appeared between the 
pretreatment to 3-month follow-up assessments. In 
addition to the changes in the targeted specific 
phobias, significant improvements were also 
observed in the participants’ non-targeted comorbid 
anxiety disorders. Patient self-efficacy did not 
increase significantly after the end of treatment. The 
families were at least moderately satisfied with the 
treatment, and there were no patients who dropped 
out of treatment. 
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